Chongqing Taihao Pharmaceutical Co Ltd

Form 483 issued March 13, 2015 · Erlang, China

Inspection
Mar 9 – Mar 13, 2015
Investigator
Kham Phommachanh
Observations
1
Pages
1
FEI number
3006088309

In short: On March 13, 2015, FDA issued a Form 483 with 1 observation to Chongqing Taihao Pharmaceutical Co Ltd in Erlang, Jiulongpo District (FEI 3006088309) after an inspection that ran Mar 9 – Mar 13, 2015. The investigator was Kham Phommachanh. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.194 (laboratory records).

At a glance

1 of 1 observations on this 483 concern laboratory controls.

Laboratory controls1

Most cited: 21 CFR 211.194 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Laboratoryjanalytical worksheet is…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Chongqing Taihao Pharmaceutical Co Ltd?

FDA listed 1 observation on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.194 (laboratory records). The opening words of each observation are shown on this page.

Who inspected Chongqing Taihao Pharmaceutical Co Ltd?

Kham Phommachanh is named on this Form 483, for the inspection of Mar 9 – Mar 13, 2015. Each investigator has a profile showing what they cite most.

When was Chongqing Taihao Pharmaceutical Co Ltd inspected by FDA?

The inspection ran Mar 9 – Mar 13, 2015, and the Form 483 is dated March 13, 2015.

How do I get the full Form 483 for Chongqing Taihao Pharmaceutical Co Ltd?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free